Identifier to cite or link to this item: https://hdl.handle.net/20.500.13003/18983
The Relationship between Therapeutic Alliance and Quality of Care in Patients with Advanced Cancer in Spain
Identifiers
eISSN: 1718-7729
WOS ID: 000979099400001
Scopus EID: 2-s2.0-85153936148
PMID: 37185386
Embase PUI: L2022892421
Share
Statistics
Item usage statisticsMetadata
Show Dublin Core item recordPublication date
2023-03-24Document type
research articleCitation
Velasco-Durántez V, Mihic-Góngora L, Coca-Membribes S, Galán-Moral R, Fernández-Montes A, Castillo-Trujillo OA, et al. The Relationship between Therapeutic Alliance and Quality of Care in Patients with Advanced Cancer in Spain. Curr Oncol. 2023 Mar 24;30(4):3580–9.Abstract
The therapeutic alliance is an important factor in successful cancer treatment, particularly for those with advanced cancer. This study aims to determine how the therapeutic alliance relates to prognostic preferences and satisfaction with the physician and medical care among patients with advanced cancer. We conducted a cross-sectional study to explore the therapeutic relationship, trust, satisfaction with healthcare, and prognostic preferences among 946 patients with advanced cancer at 15 tertiary hospitals in Spain. Participants completed questionnaires with self-reported measures. Most were male, aged > 65 years, with bronchopulmonary (29%) or colorectal (16%) tumors and metastatic disease at diagnosis. Results revealed that 84% of patients had a good therapeutic alliance. Collaborative and affective bond was positively associated with a preference to know the prognosis and satisfaction with care and decision. There was no difference in a therapeutic alliance based on clinical or sociodemographic factors. The therapeutic alliance between patient and physician is essential for successful treatment outcomes and better overall satisfaction. Therefore, it is vital for healthcare providers to focus on establishing and maintaining a strong relationship with their patients. To achieve this, transparency and care should be prioritized, as well as respect for the preferences of patients regarding the prognosis of their illness.
Publisher version
https://doi.org/10.3390/curroncol30040273MeSH
MaleSpain
Female
Treatment Outcome
Humans
Neoplasms
Cross-Sectional Studies
Therapeutic Alliance
DeCS
Resultado del TratamientoEstudios Transversales
Neoplasias
Humanos
Femenino
Alianza Terapéutica
España
Masculino